Cereno Scientific AB logo

CRNO TO1 B - Cereno Scientific AB News Story

SEK0.495 0.0  5.1%

Last Trade - 15/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £7.15m
Enterprise Value £6.49m
Revenue £n/a
Position in Universe 1678th / 1866

BRIEF-Cereno Scientific Gets Approval For II Clinical Trial In Russia

Thu 26th September, 2019 2:41pm
Sept 26 (Reuters) - Cereno Scientific AB  CRNOSb.TE :
    * CERENO SCIENTIFIC RECEIVES APPROVAL FOR THE START OF A
PHASE II
CLINICAL TRIAL IN RUSSIA
    * COMPANY INTENDS TO START STUDY FIRST HALF OF 2020 WITH
INTENTION
OF DEMONSTRATING CS1'S PREVENTATIVE EFFECT AGAINST FORMATION OF
BLOOD CLOTS AFTER ORTHOPEDIC SURGERY
    * IN MAY, CERENO SCIENTIFIC ALSO SUBMITTED AN APPLICATION TO
START
STUDY WITH CS1 TO AUTHORITIES IN BULGARIA
    * CERENO SCIENTIFIC EXPECTS APPROVAL FOR PHASE II STUDY BY
BULGARIAN AUTHORITIES THIS FALL

Source text for Eikon:  ID:nWkr324pSP 
Further company coverage:  CRNOSb.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.